FDA Counterfeit Drug Website “Icon” Considered For Education Campaign
Executive Summary
The FDA Counterfeit Drug Task Force's public education subcommittee may develop an "icon" that would allow anti-counterfeiting collaborators' websites to link to an online FDA reference page
You may also be interested in...
FDA Anti-Counterfeit Technology Policy Head Is Ex-CMS Staffer Rudolf
FDA's development of a policy on technology-based anti-counterfeiting efforts will be overseen by Senior Advisor for Medical & Health Policy Paul Rudolf, MD
FDA Counterfeit Report Seeks “Electronic Pedigree” To Aid Drug Tracking
The pharmaceutical industry's long-term goal in counterfeit prevention should be to have all drug products contain an "electronic pedigree," FDA's Counterfeit Drug Task Force interim report says
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011